A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

NCT03572387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms
Prostate Neoplasms
Prostate Cancer

Interventions

DRUG: 5-Azacitidine
DRUG: all trans retinoic acid
DRUG: Lupron

Sponsor

Icahn School of Medicine at Mount Sinai